clinical trial · NCT02307578
An Extended Access Program (EAP) for Perampanel
Primary Generalized Tonic-Clonic or Partial Onset SeizuresLennox Gastaut SyndromePerampanel
brief summary
The main objective of this EAP is to ensure that participants participating in Study E2007-G000-332, Study E2007-G000-311, E2007-G000-238, E2007-G000-338 or EAP E2007-G000-401 continue to have access to perampanel until such time that the appropriate formulation of perampanel becomes commercially available in the country in which they reside or until no participants remain in the EAP.
started
—
primary completion
—
completion
—
last updated
Sep 15, 2025
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol